326 related articles for article (PubMed ID: 27436155)
1. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
[TBL] [Abstract][Full Text] [Related]
2. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin.
Jaimes N; Marghoob AA; Rabinovitz H; Braun RP; Cameron A; Rosendahl C; Canning G; Keir J
J Am Acad Dermatol; 2015 Jun; 72(6):1027-35. PubMed ID: 25824275
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of melanoma in situ in Denmark from 1997 to 2011: results from a nationwide population-based study.
Toender A; Kjær SK; Jensen A
Melanoma Res; 2014 Oct; 24(5):488-95. PubMed ID: 24892956
[TBL] [Abstract][Full Text] [Related]
4. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.
Iorizzo LJ; Chocron I; Lumbang W; Stasko T
Dermatol Surg; 2013 Mar; 39(3 Pt 1):365-71. PubMed ID: 23356872
[TBL] [Abstract][Full Text] [Related]
5. [Dubreuilh melanoma: and epidemiologic and prognostic study].
Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
[TBL] [Abstract][Full Text] [Related]
6. The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.
Guitera P; Collgros H; Madronio CM; Goumas C; Mann GJ; Watts CG; Pereira AR; Armstrong BK; Drummond M; Morton RL; Scolyer RA; Menzies SW; Thompson JF; Cust AE
Australas J Dermatol; 2019 May; 60(2):118-125. PubMed ID: 30302753
[TBL] [Abstract][Full Text] [Related]
7. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
8. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
9. Incidence of lentigo maligna in Olmsted County, Minnesota, 1970 to 2007.
Mirzoyev SA; Knudson RM; Reed KB; Hou JL; Lohse CM; Frohm ML; Brewer JD; Otley CC; Roenigk RK
J Am Acad Dermatol; 2014 Mar; 70(3):443-8. PubMed ID: 24373777
[TBL] [Abstract][Full Text] [Related]
10. Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study.
Higgins HW; Cho E; Weinstock MA; Li TY; Qureshi A; Li WQ
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1268-1271. PubMed ID: 30451319
[TBL] [Abstract][Full Text] [Related]
11. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
12. Incidence trends of lentigo maligna and lentigo maligna melanoma in the United States from 2000 to 2019.
Chen Q; Zheng M; Ling C
Int J Dermatol; 2024 May; 63(5):647-654. PubMed ID: 38173361
[TBL] [Abstract][Full Text] [Related]
13. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
14. Association between Breslow thickness and dermoscopic findings in acral melanoma.
Mun JH; Jo G; Darmawan CC; Park J; Bae JM; Jin H; Kim WI; Kim HS; Ko HC; Kim BS; Kim MB
J Am Acad Dermatol; 2018 Nov; 79(5):831-835. PubMed ID: 29906546
[TBL] [Abstract][Full Text] [Related]
15. Trends in prognostic factors of melanoma in South Australia, 1981-1992: implications for health promotion.
Roder DM; Luke CG; McCaul KA; Esterman AJ
Med J Aust; 1995 Jan; 162(1):25-9. PubMed ID: 7845294
[TBL] [Abstract][Full Text] [Related]
16. Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
Higgins HW; Lee KC; Galan A; Leffell DJ
J Am Acad Dermatol; 2015 Aug; 73(2):181-90, quiz 191-2. PubMed ID: 26183967
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma.
Altamura D; Avramidis M; Menzies SW
Arch Dermatol; 2008 Apr; 144(4):502-6. PubMed ID: 18427044
[TBL] [Abstract][Full Text] [Related]
19. Small cell (naevoid) melanoma: a clinicopathologic study of 131 cases.
Kossard S; Wilkinson B
Australas J Dermatol; 1997 Jun; 38 Suppl 1():S54-8. PubMed ID: 10994474
[TBL] [Abstract][Full Text] [Related]
20. A decade of melanomas: identification of factors associated with delayed detection in an academic group practice.
Goodson AG; Florell SR; Boucher KM; Grossman D
Dermatol Surg; 2011 Nov; 37(11):1620-30. PubMed ID: 21790849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
